Imunon公司宣布战略重组 将削减非关键三期试验人员

美股速递
Feb 05

生物技术公司Imunon, Inc.近日启动了一项战略性重组计划,旨在优化资源配置,将公司重心聚焦于核心临床研究项目。根据重组方案,该公司将精简组织结构,裁减与关键三期临床试验非直接相关的岗位人员。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10